FDA
-
-
-
-
-
-
-
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Iberdomide in Patients with Relapsed or Refractory Multiple Myeloma
-
-
-
-
-
-
-
Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer
-
-
-
-
-
-
-
Bristol Myers Squibb Advances Lymphoma Research with New Targeted Protein Degradation and Cell Therapy Data at ASH 2025
-
-
-
-
-
-
-
Bristol Myers Squibb presents hematology pipeline data at ASH 2025
-
-
-
-
-
-
-
Bristol Myers Squibb Showcases New Long-Term and Real-World Data From Cardiovascular Portfolio at the American Heart Association Scientific Sessions 2025
-
-
-
-
-
-
-
Bristol Myers Squibb to Present Data at ESMO® 2025 Showcasing Progress of Oncology Portfolio Across Diverse Tumor Types
-
-
-
-
-
-
-
Raymond James Comments on FDA and HHS Reforms for DTC Pharma Advertising
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

